98 related articles for article (PubMed ID: 1504058)
1. Activation of human monocytes by interleukin-2 and various cytokines.
Nishimura Y; Higashi N; Tsuji T; Higuchi M; Osawa T
J Immunother (1991); 1992 Aug; 12(2):90-7. PubMed ID: 1504058
[TBL] [Abstract][Full Text] [Related]
2. Human monocytes in a long-term culture with interleukin-2 show high tumoricidal activity against various tumor cells.
Higashi N; Nishimura Y; Higuchi M; Osawa T
J Immunother (1991); 1991 Aug; 10(4):247-55. PubMed ID: 1718408
[TBL] [Abstract][Full Text] [Related]
3. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor cytotoxic potential and effect on human bone marrow GM-CFU of human LAK cells generated in response to various cytokines.
Parhar RS; Ernst P; Sheth KV; al-Sedairy ST
Eur Cytokine Netw; 1992; 3(3):299-306. PubMed ID: 1498260
[TBL] [Abstract][Full Text] [Related]
8. Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta.
Epling-Burnette PK; Wei S; Blanchard DK; Spranzi E; Djeu JY
Blood; 1993 Jun; 81(11):3130-7. PubMed ID: 8499646
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function.
Swisher SG; Economou JS; Holmes EC; Golub SH
Cell Immunol; 1990 Jul; 128(2):450-61. PubMed ID: 2113430
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages.
Ho JL; Reed SG; Sobel J; Arruda S; He SH; Wick EA; Grabstein KH
Infect Immun; 1992 May; 60(5):1984-93. PubMed ID: 1314223
[TBL] [Abstract][Full Text] [Related]
11. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
[TBL] [Abstract][Full Text] [Related]
12. IL-2 enhances c-fms expression in human monocytes.
Espinoza-Delgado I; Longo DL; Gusella GL; Varesio L
J Immunol; 1990 Aug; 145(4):1137-43. PubMed ID: 2143208
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
14. Influence of interleukin-2 on the differentiation of macrophages.
Lohmann-Matthes ML; Emmendoerffer A; Hao L
Pathobiology; 1991; 59(3):117-21. PubMed ID: 1909139
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.
Singh SM; Sone S; Inamura N; Ogura T
Int J Cancer; 1989 Jul; 44(1):170-6. PubMed ID: 2663733
[TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.
Bernasconi S; Matteucci C; Sironi M; Conni M; Colotta F; Mosca M; Colombo N; Bonazzi C; Landoni F; Corbetta G
Int J Cancer; 1995 Jan; 60(3):300-7. PubMed ID: 7829234
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
Thomassen MJ; Barna BP; Wiedemann HP; Ahmad M
J Biol Response Mod; 1990 Feb; 9(1):87-91. PubMed ID: 2156955
[TBL] [Abstract][Full Text] [Related]
18. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
[TBL] [Abstract][Full Text] [Related]
19. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of macrophage precursors to cells with LAK activity under the influence of CSF-1 and high dose IL-2.
Li H; Kniep E; Emmendörffer A; Lohmann-Matthes ML
Scand J Immunol; 1991 May; 33(5):511-20. PubMed ID: 2031145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
